Cargando…
A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
Background: Investing in the R & D sector of new medical technologies is associated with the risk of being rejected by paying organizations because of the lack of value-for-money. The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical tech...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840857/ https://www.ncbi.nlm.nih.gov/pubmed/35321374 http://dx.doi.org/10.47176/mjiri.35.141 |
_version_ | 1784650718281465856 |
---|---|
author | Goudarzi, Zahra Nikfar, Shekoufeh Kebriaeezadeh, Abbas Yousefi Zenouz, Reza Abdollahi Asl, Akbar Tavakoli, Nader |
author_facet | Goudarzi, Zahra Nikfar, Shekoufeh Kebriaeezadeh, Abbas Yousefi Zenouz, Reza Abdollahi Asl, Akbar Tavakoli, Nader |
author_sort | Goudarzi, Zahra |
collection | PubMed |
description | Background: Investing in the R & D sector of new medical technologies is associated with the risk of being rejected by paying organizations because of the lack of value-for-money. The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical technologies. Methods: Using scoping review method, we analyzed studies that investigated methods for assessing the impacts of emerging medical technologies on development. To find these studies, the Cochran Library, ISI Web of Knowledge, Embase, Ebsco and Pubmed databases from 2000 to 2018 were searched. The methodological quality of the studies was assessed using the STROBE Checklist. Two reviewers independently selected the qualified studies. Charting and collating the data were used based on the method proposed by Arksey and O'Malley. Results: Overall, 38 studies met the inclusion criteria. Sixteen methods were identified and put in five distinct categories: forecasting, Pro-HTA, Early-HTA, priority setting, and HHS were found to measure the impact of emerging technologies. The quality of these studies was acceptable. Few studies were conducted on emerging pharmaceutical technologies, and they were mostly on emerging medical devices. The Early HTA methods were often used to measure the effects of pharmaceutical technologies and medical devices technologies. The Pro-HTA method used dynamic modeling to examine the impact of medical technologies on a broad range of dimensions, while the HTA and Early-HTA methods used cost-effectiveness techniques throughout the development process. The HHS method used a multivariate decision-making technique. Conclusion: Different methods were used to investigate the impacts of emerging medical technologies. Chronologically Pro-HTA methods are new ways for investigating emerging medical technologies beyond clinical and economic impacts. Assessing the feasibility of implementing Pro-HTA in real environments deserves further research. |
format | Online Article Text |
id | pubmed-8840857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Iran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-88408572022-03-22 A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development Goudarzi, Zahra Nikfar, Shekoufeh Kebriaeezadeh, Abbas Yousefi Zenouz, Reza Abdollahi Asl, Akbar Tavakoli, Nader Med J Islam Repub Iran Review Article Background: Investing in the R & D sector of new medical technologies is associated with the risk of being rejected by paying organizations because of the lack of value-for-money. The purpose of this study is to investigate the different methods of evaluating the impacts of emerging medical technologies. Methods: Using scoping review method, we analyzed studies that investigated methods for assessing the impacts of emerging medical technologies on development. To find these studies, the Cochran Library, ISI Web of Knowledge, Embase, Ebsco and Pubmed databases from 2000 to 2018 were searched. The methodological quality of the studies was assessed using the STROBE Checklist. Two reviewers independently selected the qualified studies. Charting and collating the data were used based on the method proposed by Arksey and O'Malley. Results: Overall, 38 studies met the inclusion criteria. Sixteen methods were identified and put in five distinct categories: forecasting, Pro-HTA, Early-HTA, priority setting, and HHS were found to measure the impact of emerging technologies. The quality of these studies was acceptable. Few studies were conducted on emerging pharmaceutical technologies, and they were mostly on emerging medical devices. The Early HTA methods were often used to measure the effects of pharmaceutical technologies and medical devices technologies. The Pro-HTA method used dynamic modeling to examine the impact of medical technologies on a broad range of dimensions, while the HTA and Early-HTA methods used cost-effectiveness techniques throughout the development process. The HHS method used a multivariate decision-making technique. Conclusion: Different methods were used to investigate the impacts of emerging medical technologies. Chronologically Pro-HTA methods are new ways for investigating emerging medical technologies beyond clinical and economic impacts. Assessing the feasibility of implementing Pro-HTA in real environments deserves further research. Iran University of Medical Sciences 2021-10-26 /pmc/articles/PMC8840857/ /pubmed/35321374 http://dx.doi.org/10.47176/mjiri.35.141 Text en © 2021 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Review Article Goudarzi, Zahra Nikfar, Shekoufeh Kebriaeezadeh, Abbas Yousefi Zenouz, Reza Abdollahi Asl, Akbar Tavakoli, Nader A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development |
title | A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development |
title_full | A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development |
title_fullStr | A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development |
title_full_unstemmed | A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development |
title_short | A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development |
title_sort | scoping review of different methods of assessing the impact of new medical technologies at early stages of development |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840857/ https://www.ncbi.nlm.nih.gov/pubmed/35321374 http://dx.doi.org/10.47176/mjiri.35.141 |
work_keys_str_mv | AT goudarzizahra ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT nikfarshekoufeh ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT kebriaeezadehabbas ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT yousefizenouzreza ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT abdollahiaslakbar ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT tavakolinader ascopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT goudarzizahra scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT nikfarshekoufeh scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT kebriaeezadehabbas scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT yousefizenouzreza scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT abdollahiaslakbar scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment AT tavakolinader scopingreviewofdifferentmethodsofassessingtheimpactofnewmedicaltechnologiesatearlystagesofdevelopment |